Literature DB >> 22566418

Williams-Beuren syndrome hypercalcemia: is TRPC3 a novel mediator in calcium homeostasis?

Emmanuel Letavernier1, Anita Rodenas, Dominique Guerrot, Jean-Philippe Haymann.   

Abstract

Williams-Beuren syndrome (WBS) is a neurodevelopmental disorder associated with hypercalcemia of unknown origin. This syndrome results from the deletion of contiguous genes on chromosome 7, including the general transcription factor IIi gene. The general transcription factor IIi gene encodes TFII-I, which suppresses cell-surface accumulation of transient receptor potential C3 (TRPC3) channels, involved in calcium transport in lymphocytes. We describe the case of a patient with WBS with hypercalcemia associated with abnormal TRPC3 expression. Analysis of peripheral lymphocytes revealed a sharp increase in TRPC3 expression, compared with control patients. To investigate the potential role of TRPC3 in calcium homeostasis, we performed specific immunostaining on the intestine and the kidney, major calcium-regulating tissues. We provide the first demonstration that TRPC3 is expressed in normal digestive epithelium and renal tubules in control patients, and overexpressed in the intestine in the patient with WBS. Taken together, these data suggest that calcium metabolism abnormalities observed in WBS may be attributable to TFII-I haploinsufficiency and subsequent TRPC3 overexpression, thereby increasing both digestive and renal calcium absorption. This original observation prompts further investigation of TRPC3 as a novel actor of calcium homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22566418     DOI: 10.1542/peds.2011-2507

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

Review 1.  Calcium-permeable ion channels in the kidney.

Authors:  Yiming Zhou; Anna Greka
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-30

Review 2.  The contribution of GTF2I haploinsufficiency to Williams syndrome.

Authors:  Thanathom Chailangkarn; Chalongrat Noree; Alysson R Muotri
Journal:  Mol Cell Probes       Date:  2018-01-03       Impact factor: 2.365

3.  Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis.

Authors:  Youakim Saliba; Ralph Karam; Viviane Smayra; Georges Aftimos; Joel Abramowitz; Lutz Birnbaumer; Nassim Farès
Journal:  J Am Soc Nephrol       Date:  2014-12-05       Impact factor: 10.121

4.  Hypercalcemia in Patients with Williams-Beuren Syndrome.

Authors:  Sampat Sindhar; Michael Lugo; Mark D Levin; Joshua R Danback; Benjamin D Brink; Eric Yu; Dennis J Dietzen; Amy L Clark; Carolyn A Purgert; Jessica L Waxler; Robert W Elder; Barbara R Pober; Beth A Kozel
Journal:  J Pediatr       Date:  2016-08-26       Impact factor: 4.406

Review 5.  Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.

Authors:  Rong Ma; Sarika Chaudhari; Weizu Li
Journal:  Antioxid Redox Signal       Date:  2016-03-18       Impact factor: 8.401

6.  Endocrine dysfunctions in children with Williams-Beuren syndrome.

Authors:  Yoon-Myung Kim; Ja Hyang Cho; Eungu Kang; Gu-Hwan Kim; Eul-Ju Seo; Beom Hee Lee; Jin-Ho Choi; Han-Wook Yoo
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-03-31

7.  Vasopressin regulates renal calcium excretion in humans.

Authors:  Guillaume Hanouna; Jean-Philippe Haymann; Laurent Baud; Emmanuel Letavernier
Journal:  Physiol Rep       Date:  2015-11

8.  Williams-Beuren syndrome associated with single kidney and nephrocalcinosis: a case report.

Authors:  Kamel Abidi; Manel Jellouli; Rania Ben Rabeh; Yousra Hammi; Tahar Gargah
Journal:  Pan Afr Med J       Date:  2015-11-23

9.  Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model.

Authors:  Paula Ortiz-Romero; Cristina Borralleras; Mònica Bosch-Morató; Biuse Guivernau; Guillermo Albericio; Francisco J Muñoz; Luis A Pérez-Jurado; Victoria Campuzano
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

10.  Pamidronate Rescue Therapy for Hypercalcemia in a Child With Williams Syndrome.

Authors:  Sami A Sanjad; Bilal Aoun; Halim Yammine; Amina Bassyouni; Pascale E Karam
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.